Skip to main content

Together we are beating cancer

Donate now

Research and trials

Showing 12 out of 1711 results

The current consensus is that, right now, there isn’t a large enough body of evidence to prove that cannabis (or any of its active compounds or derivatives) can reliably treat any form of cancer but the medical use of cannabis to treat cancer-related chronic pain is approved in the UK. The current consensus is that, right now, there isn’t a large enough body of evidence to prove that cannabis (or any of its active compounds or derivatives) can reliably treat any form of cancer but the medical use of cannabis to treat cancer-related chronic pain is approved in the UK.

by Cancer Research UK | In depth | 13 May 2022

13 May 2022

A patient receiving chemotherapy

A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer. A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.

by Jacob Smith | News | 2 May 2022

2 May 2022

Researchers at work in a Cancer Research UK laboratory

You may not know that as well as funding cancer research, we also work with industry and academia to develop promising ideas and turn them into real benefit for patients. Find out about Cancer Research Horizons. You may not know that as well as funding cancer research, we also work with industry and academia to develop promising ideas and turn them into real benefit for patients. Find out about Cancer Research Horizons.

by Lilly Matson | Analysis | 26 April 2022

26 April 2022

Doctors in a hospital corridor

A new study from the ICBP has reported international differences in proportions of cancer emergency presentations, and links this to differences in cancer survival. A new study from the ICBP has reported international differences in proportions of cancer emergency presentations, and links this to differences in cancer survival.

by Jacob Smith | Analysis | 7 April 2022

7 April 2022

A patient having a consultation with their doctor

There’s no ‘right’ way to check certain parts of your body for cancer, but here’s what you need to keep in mind when self-checking. There’s no ‘right’ way to check certain parts of your body for cancer, but here’s what you need to keep in mind when self-checking.

by Amy Hirst | In depth | 29 March 2022

29 March 2022

Forty years ago, hints of a new component of the immune system caused a stir. Here, we chart the story of gamma delta T cells from discovery to clinical trials... Forty years ago, hints of a new component of the immune system caused a stir. Here, we chart the story of gamma delta T cells from discovery to clinical trials...

by Cancer Research UK | In depth | 18 March 2022

18 March 2022

  • Science & Technology
  • Health & Medicine
  • For Researchers

Why diversity in STEM is vital to cancer research

Cancer Research UK has an important role in fostering a diverse and inclusive research environment, and here we give a brief summary of our response to the consultation and explain why this matters for cancer research… Cancer Research UK has an important role in fostering a diverse and inclusive research environment, and here we give a brief summary of our response to the consultation and explain why this matters for cancer research…

by Cancer Research UK | Analysis | 3 March 2022

3 March 2022

This entry is part 4 of 10 in the series Diversity in research
Seb
  • Science & Technology
  • For Researchers

Embracing a full spectrum of researchers

For drug discovery scientist Sebastian Greenhough, a late diagnosis of autism made sense of several things – but something it certainly didn’t do was stand in the way of his research For drug discovery scientist Sebastian Greenhough, a late diagnosis of autism made sense of several things – but something it certainly didn’t do was stand in the way of his research

by Cancer Research UK | Analysis | 24 February 2022

24 February 2022

This entry is part 5 of 10 in the series Diversity in research